Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 10;16:3289–3296. doi: 10.2147/OPTH.S376141

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Ohe et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Flowchart of the specimen-selection procedure in this study. The specimens, which were taken from 30 eyes of patients with granulomatous uveitis that satisfied more than two items of seven intraocular clinical signs suggestive of ocular sarcoidosis, were classified according to the diagnostic criteria for sarcoidosis. Eleven patients did not meet the criteria and were classified into the sarcoid uveitis-suspected group. We used 16 eyes from these 11 patients for vitrectomy. Ten patients met the criteria and were classified into the sarcoidosis group. We used 14 eyes from these 10 patients for vitrectomy. To detect epithelioid granuloma/epithelioid cells, liquid-based cytology and the cell block procedure were performed on vitreous body specimens obtained by vitrectomy.